Clinical Trials Directory

Trials / Unknown

UnknownNCT03984344

Theta Burst Stimulation in Anorexia Nervosa

A Feasibility Trial of Theta Burst Stimulation in Anorexia Nervosa (AN)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
King's College London · Academic / Other
Sex
All
Age
13 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Anorexia Nervosa (AN) is a life-threatening eating disorder characterised by an intense fear of weight gain and disturbed body image, which motivates severe dietary restriction or other weight loss behaviours (e.g. purging). Treatment efficacy in adults with AN remains low: only a small percentage of individuals fully recover, and dropout rates are high. For adolescents with a relatively short term illness duration (under 3 years), family-based therapy has been associated with more favourable outcomes. However, for those adolescents with a longer illness duration (over 3 years), there are no specific treatments associated with positive long-term outcomes and these individuals are at risk of developing a severe and enduring form of the illness (SE-AN). In part, treatment can be problematic due to ambivalence, which is reflected in poor take-up of certain treatments (e.g. pharmacological treatments that lead to weight gain) and high drop-out rates. Repetitive transcranial magnetic stimulation (rTMS) has demonstrated efficacy for treatment of AN in adults and improving treatment adherence. However, this has yet to be investigated in adolescents with AN. This study will use a novel type of rTMS, theta burst stimulation (TBS), including intermittent TBS (iTBS) and continuous TBS (cTBS). TBS takes as little as a few minutes duration compared to the classical rTMS protocol which takes approximately 37.5 minutes. In addition, TBS has been found to produce longer after-effects of the induced plastic changes and has a lower stimulation intensity, which may therefore be more practical and potentially safer to administer in people with AN. Thus, the aim of this proof-of-concept trial is to obtain preliminary data on the safety and short-term (i.e. up to 24 hours) effects of a single session of iTBS and cTBS, compared to sham TBS, on reducing core symptoms of AN.

Conditions

Interventions

TypeNameDescription
DEVICEIntermittent Theta Burst StimulationThe Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer active TBS.
DEVICEContinuous Theta Burst StimulationThe Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer active TBS.
DEVICESham Theta Burst StimulationThe Magstim Rapid2 Magnetic Stimulator (Magstim ®, UK) will be used to administer TBS using a sham Magstim coil.

Timeline

Start date
2020-02-18
Primary completion
2022-12-01
Completion
2023-02-01
First posted
2019-06-13
Last updated
2022-08-19

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03984344. Inclusion in this directory is not an endorsement.